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Abstract
In order to determine the modulation of anxiolytic and panicolytic-like effects of diazepam by the hormonal cycle of female rats, 
male and female rats – the latter divided per estrous cycle phase (estrus, diestrus, metaestrus and proestrus) – were tested in the 
elevated T-maze, a behavioral model of panic and anxiety. Diazepam (0.5, 1.0 and 2.0 mg/kg) or saline solution was injected in 
individual animals that were submitted to one session in the elevated T-maze 25 min after drug/saline administration. The test 
consisted of three avoidance trials and one escape trial, separated by a 30 s interval, during which the animals were isolated 
in individual cages. The avoidance trials began with the animal being placed at the end of the maze’s enclosed arm. The time 
necessary for the animal to leave the central square was considered as the response’s latency. The trials that exceeded 300 s 
were considered as failures. Results demonstrate a decrease in the effects of diazepam in inhibitory avoidance (anxiety) trials in 
females in diestrus and proestrus, but no relation of gender or estrous cycle on diazepam effects on escape trials (fear). The results 
support the hypothesis that down-regulation of GABAA receptors by activation of nuclear estrogen receptors and induction 
of PKC-mediated GABAA receptor phosphorylation by activation of surface estrogen receptors in raphe neurons underlie the 
modulation of diazepam sensitivity by estrogen. Keywords: diazepam, estrous cycle, estrogen, anxiety, elevated T-maze.
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Introduction
Anxiety is an emotional state that emerges under 
situations in which risk is probable, but not certain. 
This state is associated with behaviors linked to defense 
reactions, that is, a set of species-specific behavioral 
strategies which were selected in evolutionary history 
to increase the possibilities of survival in dangerous 
situations as well as the autonomic activation that 
accompanies these behaviors in danger situations, such 
as cautious investigation (Blanchard & Blanchard, 1988; 
Fanselow & Lester, 1988). 
In humans, anxiety is manifested by clinical 
alterations with variable severity distributed along 
the anxiety spectrum, and is usually treated with 
benzodiazepines, a class of substances that act on 
the GABAA receptor complex by allosteric modulation. 
GABA is a neurotransmitter of mostly inhibitory 
action that is present in about 30% of the synapses in 
the central nervous system (Olsen, 2002). The GABAA 
receptor complex prevails on mammalian nervous 
systems; it receives, besides the endogenous GABA 
neurotransmitter, benzodiazepines, barbiturates and 
other anxiolytic drugs, hormones and anticonvulsants 
(Berezhnoy, Gravielle, & Farb, 2007; Schmitt, Luddens, 
& Hiemke, 2000). Most ligands which modulate 
GABAA-associated chloride currents seem to act through 
allosteric modulation of the opening of a chloride 
channel, altering the probability that this ligand-gated 
channel is in an “open” state (Berezhnoy et al., 2007; 
Costa, 1998; Olsen, 2002). The actions of GABA at the 
many GABAA receptor subtypes can also be agonized 
or allosterically modulated by a variety of progesterone 
metabolites (Puia et al., 1990). Neurosteroids given in 
high doses can gate chloride channels associated with 
GABAA receptors even in the absence of GABA (Puia, 
Ducic, Vicini, & Costa,  1993), an effect that has been 
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observed with barbiturates, but not benzodiazepines 
(Costa, 1998). Progesterone derivatives positively 
modulate GABA action on GABAA receptors (Puia et 
al., 1993); pregnelone sulfate (a progesterone derivative) 
negatively modulates chloride currents gated by 
GABA only in high concentrations (Puia et al., 1993). 
Interestingly, this neurosteroid is most efficient in its 
GABA-potentiating action in recombinant receptors 
including the γ1 subunit – a subunit whose mRNA is 
expressed predominantly in native GABAA receptors 
located in glial cells (McKernan & Whiting, 1996).
Besides the direct action of progesterone metabolites 
on GABAA receptors, estrogen has also been implicated 
in the regulation of GABAA receptor activity (Bitran 
& Dowd, 1995; Guilinello, Gong, Li, & Smith, 2001; 
Hamon et al., 1983; Herbison, 1997; Herbison & 
Fénelon, 1995; Zhu & Vicini, 1997), despite the lack of 
evidence to suggest that this steroid is a direct allosteric 
modulator of the GABAA receptor. A major contributing 
factor in the wide array of behaviors which are mediated 
by estrogen and progesterone is the existence of two 
different estrogen receptors in the brain: Estrogen 
Receptor-α (ER-α) and Estrogen Receptor-β (ER-β). 
In rodent brains, the first are expressed strongly in 
hypothalamic nuclei which are closely related to 
reproductive physiology, as well as in the pons and 
medulla (Österlund, Kuiper, Gustafsson, & Hurd, 1998; 
Shughrue & Merchenthaler, 2001). ER-β, however, is 
expressed widely in the forebrain (neocortex as well 
as limbic forebrain cell nuclei) and raphe (Österlund, 
Gustafsson, Keller, & Hurd, 2000; Österlund et al., 1998; 
Shughrue & Merchenthaler, 2001; Silveira, Zangrossi, 
Viana, Silveira, & Graeff, 2001). Consistent with this 
distribution, for example, mice which were knocked 
out of either ER-α or ER-β demonstrated differences 
in exploratory behavior and activity levels: while ER-α 
KO mice presented differences in spontaneous wheel 
running, ER-β KO mice had an anxious phenotype 
(Krezel, Dupont, Krust, Chambon, & Chapman, 2001; 
Ogawa, Chan, Gustafsson, Korach, & Pfaff, 2003), with 
decreased exploration of the center of an open-field 
(OF) and decreased exploration of the open arms of an 
elevated plus-maze.
The estrous cycle of rodents lasts for about four 
to five days, and has four phases, denominated estrus, 
metaestrus, diestrus and proestrus. Estrus corresponds 
to ovulation, and progesterone is found at its peak 
level during this phase. Metaestrus corresponds to 
the phase between cycles, and hormone levels are 
restored to the “baseline” level in the vagina. At the 
end of the metaestrus phase, the diestrus phase begins, 
a period where estrogen’s action takes place. Proestrus 
corresponds to the peak on the action of estrogens.
Many studies explored the different phases of 
the estrous cycle in relation to fear and anxiety-
like behavior, focusing mainly on estrus (the phase 
in which progesterone is highest) and proestrus (the 
phase in which estrogen is highest) (for a review, 
cf. Morgan, Schulking, & Pfaff, 2004). John Archer 
(1975) observed that females in estrus not only 
have an increase in behaviors involving gross motor 
activity, but also are more reactive to fearful stimuli. 
In terms of conditioned fear, females in proestrus 
acquire eye-blink responses faster than females in 
other stages (Shors, Lewczyk, Pacynski, Mathew, & 
Pickett,  1998), exhibit facilitated acquisition of two-
way avoidance (Sfikakis, Spyraki, Sitaras, & Varonos, 
1978) and less freezing to context in a Pavlovian fear 
conditioning paradigm (Markus & Zecevic, 1997). 
Cycling female rats in proestrus or estrus show less 
activity in the open-field than females in other stages 
(Díaz-Véliz, Benavides, Butrón, Dussabaut, & Mora, 
1999), which the authors interpreted as a measure 
of increased fear. Another study (Frye, Petralia, & 
Rhodes, 2000) reported that female rats in proestrus 
and estrus were more active in the periphery of the 
OF (i.e., increased thigmotaxis) but not in the center, 
which is a less controversial measure of anxiety 
(Treit & Fundytus, 1989). These differences were 
associated with increased hippocampal content of 
progesterone and 3α,5 α –THP. The latter results are 
partially contradictory with observations by Rhodes 
and Frye (2001) that the inhibition of progesterone 
metabolism in the hippocampus during estrus had 
pro-exploratory and antinociceptive effects, also 
producing an anxiogenic profile. To complicate 
matters further, in the elevated plus-maze (EPM), 
females in proestrus present decreased anxiety 
(Frye et al., 2000; Gouveia & Morato, 2002; Mora, 
Dussabaut, & Díaz-Véliz,  1996; Nomikos & Spyraki, 
1988). Morgan and colleagues (2004) argued that 
these differences could be accounted for by different 
dependencies on ER-α or ER-β receptors, as well as 
the different neuroanatomical patterns of expression 
for both receptors. In addition, one could argue that 
the modulation exerted by estrogen and progesterone 
is widespread in different systems which mediate 
anxiety, such as GABA (Bitran & Dowd, 1995; Hamon 
et al., 1983; Herbison, 1997; Herbison & Fénelon, 
1995; Maggi & Perez, 1984), serotonin (Fernández-
Guasti, Martínez-Mota, Estrada-Camarenas, Contreras, 
& Lórez-Rubalcava,  1999; Le Saux & Di Paolo, 2005; 
Maswood, Stewart, & Uphouse,  1995; Maswood, 
Truitt, Hotema, Caldarola-Pastuszka, & Uphouse, 
1999; Österlund, Hallin, & Hurd, 2000; Robichaud & 
Debonnel, 2005; Rubinow, Schmidt, & Roca, 1998), 
oxytocin (Dellovade, Zhu, & Pfaff, 1999; Koksma et 
al., 2003), and protein kinase Cε (Fancsik, Linn, & 
Tasker, 2000; Hodge et al., 2002).
The elevated T-maze is an anxiety and memory 
animal model developed from the classic elevated 
plus-maze by the elimination of one of the maze’s 
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enclosed arms. In relation to other animal models, the 
elevated T-maze allows the differentiation between the 
behavioral elements that compose generalized anxiety, 
fear, and learned anxiety, based on the animal’s natural 
aversion to open and elevated spaces, thus enabling 
clearer discriminations between the anxiolytic and 
panicolytic effects of diverse drugs (Bueno, Zangrossi, 
& Viana, 2007; Graeff, Viana, & Tomaz, 1993; 
Zangrossi & Graeff, 1996): while inhibitory avoidance 
of the open arm is supposed to represent learned fear, 
the escape response from the open arm would represent 
innate fear. Anxiolytic-like effects are observed in the 
impairment of inhibitory avoidance, while impairment 
of escape responses is associated with panicolytic-like 
effects (Graeff et al., 1993; Zangrossi & Graeff, 1996). 
Diazepam selectively impairs inhibitory avoidance 
in the elevated T-maze, leaving escape responses 
unchanged (Graeff, Netto, & Zangrossi,  1998; Graeff 
et al., 1993; Viana, Tomaz, & Graeff, 1994; Zangrossi 
& Graeff, 1996). In a previous work (Gouveia, dos 
Santos, Felisbino, Afonseca, Antunes, & Morato, 
2004), we demonstrated that the estrous cycle modulates 
different parameters of conditioned and unconditioned 
fear in this model, with females in proestrus and estrus 
showing impairment in the acquisition of inhibitory 
avoidance but no alterations in escape, while females 
in diestrus showed increased baseline anxiety. In the 
present work, we assessed the effects of the estrous 
cycle on benzodiazepine sensitivity of rats using the 
elevated T-maze model. 
Methods
Subjects
Thirty-two male rats and 128 female rats (Rattus 
novergicus, Wistar, UNESP, Botucatu) were used in the 
experiment. Animals were distributed in groups (n = 
8) based on sex, drug dose and (in the case of females) 
estrous cycle phase. Subjects were kept in collective cages 
(five per cage) in the same room with ad libitum water 
and food, as well as controlled light/dark cycle (12L:12D, 
lights on at 0700) and temperature (25° C ± 2° C).
Apparatus
The elevated T-maze consisted of two opposed open 
arms (50x10 cm) and one enclosed arm (50x10x40 cm), 
perpendicular to the other two. The maze’s arms bind to a 
10x10 cm central area. The apparatus was elevated 50 cm 
above the ground. The whole maze was made of wood 
and the surfaces of its arms were covered with formica.
Drug
Diazepam (0.5, 1.0 and 2.0 mg/kg, Roche Products 
Ltd., Brazil) was dissolved in saline solution (0.9%) as 
served as control solution. Diazepam and control solution 
were injected intraperitoneally at a total volume of 4 ml/kg.
Procedure
Initially, females had their estrous cycle recorded 
with daily collection of vaginal material for a period 
that varied between 5-6 days. Females with an irregular 
cycle were discarded. After verification, the animals 
were divided in groups based on sex, and females were 
divided in subgroups according to the phase of their 
estrous cycle (estrus, diestrus, metaestrus or proestrus). 
Further subdivision was made as animals were divided 
according to drug dosage (saline; 0.5; 1.0; and 2.0 mg/
kg), resulting in nested groups with eight animals each. 
Each experimental subject underwent a single test 
session that began 25 minutes after the intraperitoneal 
injection of diazepam. 
The test consisted of three avoidance trials and one 
escape trial separated by 30 s intervals in which the 
animals were isolated in individual cages. The avoidance 
trials began with the animal being placed at the end of the 
maze’s closed arm. The time necessary for the animal to 
leave the central square was considered as the response 
latency. Trials that exceeded 300 s were considered as 
failures. After the inhibitory avoidance test, an escape 
test was executed, where the animal was placed at the 
end of the right open arm and the latency time to cross 
the central square was recorded. Thus, latencies to leave 
the compartment in which the animal was first placed 
were the outcome assessed in both inhibitory avoidance 
and escape trials.
The maze was cleaned after each session to avoid 
interference of the odor of a previously tested animal on the 
behavior of the animal observed on the following session.
The experiments were performed in compliance 
with the recommendations of the SBNeC (Brazilian 
Society for Neuroscience and Behavior), which are 
based on NIH’s Guide for Care and Use of Laboratory 
Animals. Procedures and animal housing conditions were 
approved by the UNESP Research Ethics Committee.
Statistical analysis
Data are presented as means ± S.E.M. The results of 
the inhibitory avoidance trials were analyzed with a two-
way repeated measure analysis of variance (between-
subjects factors: dose and hormonal state; within-
subjects factor: trial). Data from the escape trials were 
analyzed with a two-way analysis of variance (between-
subjects factors: dose and hormonal state). Tukey post-
hoc tests were performed whenever appropriate, and 
statistically significant p-values were set as ≤ .05.
Results
Figure 1 presents latency times to leave the closed 
arm, a measure of inhibitory avoidance, across trials. 
As expected, latency times increased monotonically 
as trials occurred, irrespective of estrous cycle phase 
or drug dose. However, this relationship was broken in 
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diestrus females taking the 2.0 mg/kg dose.
Since the data presented statistically significant 
sphericity (W = .876, p <.005), all subsequent analyses 
assumed sphericity. Within-subjects main effects 
of trial number (F[2,280] = 92.067, p < .005) and dose 
within trial (F[6,280] = 4.313, p < .005) were found, but 
hormonal state did not exert significant effects on this 
variable (F[8,280] = 1.667, p = .106). No interaction 
between dose and hormonal state was found within 
trial number (F[24,280] = 1.276, p = .179).
Diazepam doses (F[3,140] = 3.842, p = .011) and 
hormonal status (F[4,140] = 3.363, p = .012) produced 
main between-subject effects on the mean latency times, 
and an interaction between both factors (F[12,140] = 4.514, 
p < .005 was also observed. Post-hoc tests discriminated 
the underlying differences; the results of these analyses 
can be found in Figure 1.
Figure 2 presents the effects of diazepam and gender/
hormonal status on the latency to exit the central square. 
No main effects of diazepam dose (F[3,140] = 1.666, p = .34) 
Figure 1. Estrous cycle modulates inhibitory avoidance acquisition in the elevated T-maze and affects diazepam sensitivity in 
that task. The charts represent mean (± S.E.M.) latencies to leave the closed arm of the elevated T-maze as a function of gender 
and estrous cycle phase, as well as diazepam dose. Asterisks (*) represent differences within a given dose, while the double 
dagger symbol (‡) represents differences against controls (0.9% saline).
Figure 2. Estrous cycle does not have an effect in escape trials in the elevated T-maze, and diazepam effects are detectable only 
at higher doses, suggesting motor impairment. The charts represent mean (± S.E.M.)latencies to leave the central square of the 
elevated T-maze as a function of gender and estrous cycle phase, as well as diazepam dose. Asterisks (*) represent differences 
within a given dose, while the double dagger symbol (‡) represents differences against controls (0.9% saline).
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or hormonal status (F[4,140] = .223, p = .2230 were found; 
however, a statistically significant interaction between 
both factors was observed (F[12, 138] = 1.857, p = .045).
Discussion
The present article tested the influence of estrous 
cycle phase on the anxiolytic and panicolytic-like 
effects of diazepam, using the elevated T-maze, a 
rodent anxiety model. The results indicate a modulatory 
action of gender and hormonal status on the effects of 
diazepam in the elevated T-maze, evident in anxiety-
like (inhibitory avoidance) but not fear-like behaviors 
(escape), in the diestrus and proestrus phases, 
correspondent to an increase in the circulating levels 
of estrogen present in female rats’ organisms. These 
results are consistent with available evidence regarding 
increased anxiety and estrogen levels (Bitran & Dowd, 
1995; Díaz-Véliz, Alarcón, Espinoza, Dussabaut, & 
Mora, 1997; Díaz-Véliz, Soto, Dussabaut, & Mora, 
1989; Gouveia et al., 2004; Gouveia & Morato, 2002). 
Females in diestrus and proestrus also presented 
reduced latency times in inhibitory avoidance 
trials in relation to males and females in metaestrus 
and diestrus, suggesting an anxiolytic effect of 
progesterone also consistent with the literature (Frye 
et al., 2000; Frye & Walf, 2002; Frye, Walf, Rhodes, & 
Harney, 2004; Guilinello et al., 2001; Rhodes & Frye, 
2001; Smith et al., 1998). The significant increases in 
latency times on males’ inhibitory avoidance trials are 
proportional to the dose of diazepam, suggesting not 
a neuromodulatory phenomenon, but a sedative and 
ataxic effect of this benzodiazepine.
The differential result in anxiety - but not panic 
- is consistent with the observation that estrous cycle 
modulates responses to anxiogenic stimuli in the elevated 
T-maze, but not to panicogenic stimuli (Gouveia et 
al., 2004). It also indicates that the site of action is not 
restricted to the ventromedial hypothalamic nucleus, 
dorsal periaqueductal gray area or medial nucleus of the 
amygdala, since facilitation of GABA activity in these 
regions produces effects on panic measures in the elevated 
T-maze (Bueno, Zangrossi, Nogueira, Soares, & Viana, 
2005; Bueno et al., 2007; Herdade, Strauss, Zangrossi, 
& Viana, 2006). Exposure to the inhibitory avoidance 
task of this model increases Fos-like immunoreactivity 
in the medial amygdaloid nucleus, anterior hypothalamic 
nucleus and raphe nuclei, while the escape task increases 
Fos-like immunoreactivity in the basolateral amygdaloid 
nucleus and in the dorsal periaqueductal gray area 
(Silveira et al., 2001). Accordingly, the modulation of 
diazepam sensitivity by estrogen, being anxiety-related, 
is likely to have happened at the level of the raphe nuclei, 
a set of structures presenting surface and nuclear estrogen 
and progestin receptors (Alves, Weiland, Hayashi, & 
McEwen, 1998). Estrogen and progesterone modulate 
the firing of raphe neurons (Robichaud & Debonnel, 
2004, 2005), and serotonergic neurons in the raphe have 
been associated with the modulation of anxiety-like 
behavior (Graeff, 2002; Graeff, Viana, & Mora, 1997). 
Interestingly, the immunoreactivity of estrogen and 
progestin receptors in the raphe does not coincide with 
tryptophan hydrolase immunoreactivity, suggesting that 
the targets of steroid modulation of raphe serotonergic 
activity are not serotonergic neurons (Alves et al., 1998).
Such differences between males and females in 
diestrus and proestrus may be related to a modulatory 
action of estrogen over the GABAA receptor complex 
and the benzodiazepine subunit. This action would be 
manifested by a diminished efficacy of diazepam during 
diestrus and proestrus – precisely the phases of the 
estrous cycle that present increased estrogen activity. 
One possible mechanism involves the activation 
of membrane-associated estrogen receptors, whose 
response is mediated by the second messenger 
protein kinase C (Kelly & Levin, 2001; Kelly & 
Wagner, 1999; Le Saux & Di Paolo, 2005). PKC 
would phosphorylate GABAA receptors, decreasing 
the efficacy of benzodiazepines. This hypothesis is 
strengthened by the observation that phosphorylation of 
these receptors through the action of PKC determines 
sensitivity to neurosteroids (Fancsik et al., 2000), 
together with evidence that mice knocked out for the ε 
isoform of PKC are more sensitive to the modulation 
of chloride uptake by allopregnanolone, alphaxalone, 
and preganolone (Hodge et al., 2002) and data on the 
behavioral and neurochemical effects of alcohol and 
benzodiazepines (Choi, Wang, Dadgar, Chang, & 
Messing, 2002; Hodge et al., 1999; Olive, Mehmert, 
Messing, & Hodge, 2000; Olive, Mehmert, Nannini, 
Camarini, Messing, & Hodge, 2001). 
Another possibility is that activation of nuclear β 
estrogen receptors in raphe neurons could down-regulate 
GABAA receptor density, an effect that was observed 
in the preoptic area and in the bed nucleus of the stria 
terminalis of female rats (Herbison & Fénelon, 1995). 
The relative contribution of effects mediated through 
genomic modulation of GABAA receptors and effects 
mediated through receptor phosphorylation to the effects 
of estrogen on behavior is yet undetermined, and it 
should be considered that these two mechanisms may be 
operating in association (Brandon, Uren, Kittler, Wang, 
Olsen, & Parker, 1999; Kumar, Sieghart, & Morrow, 
2002; Moss & Smart, 1996). The association between the 
effects of diazepam and progesterone levels is indicated 
by the effectiveness of the drug (i.e., diminished latency 
times) in the estrus phase, when this hormone is found at 
its peak level, and is probably due to the direct action of 
progesterone and its metabolites on allosteric sites of the 
GABAA receptor. Diazepam seems also to be effective 
in the metaestrus phase, where no hormonal activity is 
found in the female rats’ organisms.
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